Aura Biosciences
AURA
75 hedge funds and large institutions have $300M invested in Aura Biosciences in 2024 Q2 according to their latest regulatory filings, with 12 funds opening new positions, 34 increasing their positions, 20 reducing their positions, and 15 closing their positions.
70% more repeat investments, than reductions
Existing positions increased: 34 | Existing positions reduced: 20
0.77% more ownership
Funds ownership: 79.5% → 80.27% (+0.77%)
0% more funds holding in top 10
Funds holding in top 10: 2 → 2 (0)
2% less capital invested
Capital invested by funds: $307M → $300M (-$6.64M)
4% less funds holding
Funds holding: 78 → 75 (-3)
20% less first-time investments, than exits
New positions opened: 12 | Existing positions closed: 15
57% less call options, than puts
Call options by funds: $6K | Put options by funds: $14K
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
LFCM
Long Focus Capital Management
San Juan,
Puerto Rico
|
+$4.11M |
| 2 |
BlackRock
New York
|
+$4.11M |
| 3 |
Adage Capital Partners
Boston,
Massachusetts
|
+$3.08M |
| 4 |
LCS
Levin Capital Strategies
New York
|
+$1.58M |
| 5 |
ACM
ADAR1 Capital Management
Austin,
Texas
|
+$1.49M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
-$9.8M |
| 2 |
JFG
Jefferies Financial Group
New York
|
-$1.75M |
| 3 |
Verition Fund Management
Greenwich,
Connecticut
|
-$1.19M |
| 4 |
Ensign Peak Advisors
Salt Lake City,
Utah
|
-$771K |
| 5 |
Fidelity Investments
Boston,
Massachusetts
|
-$470K |
AURA Hedge Fund Activity: Q2 2024 in Review
75 of the 6,935 institutional investors tracked by Wall St. Rank reported a position in Aura Biosciences (AURA) for Q2 2024, worth a combined $300M — down 2.2% from $307M a quarter earlier.
Sellers outnumbered buyers: 15 funds closed out of AURA and 12 opened new positions — a net loss of 3 holders — while 20 trimmed existing stakes and 34 added.
The largest buyer was Long Focus Capital Management, adding an estimated $4.11M. The largest seller was Citadel Advisors, cutting an estimated $9.8M.
- 75 institutional investors held Aura Biosciences (AURA) as of Q2 2024, down from 78 in Q1 2024.
- Funds reported $300M of Aura Biosciences stock for Q2 2024, down 2.2% quarter-over-quarter.
- 12 funds opened new Aura Biosciences positions in Q2 2024 and 15 closed out, a net change of -3 holders.
- The largest Aura Biosciences buyer in Q2 2024 was Long Focus Capital Management, an estimated $4.11M added.
- The largest Aura Biosciences seller in Q2 2024 was Citadel Advisors, an estimated $9.8M sold.
Based on aggregated 13F filings for Q2 2024.